On October 23rd, 2014, we updated our
By continuing to use LinkedIn’s SlideShare service, you agree to the revised terms, so please take a few minutes to review them.
To compare the effectiveness and safety of prophylactic enteral probiotics administration versus placebo or no treatment in the prevention of severe (stage II or more) NEC and/or sepsis in preterm infants
The secondary objective
To conduct a subgroup analysis to investigate the effect of probiotics in extreme low birth weight infants (infants with birth weight <1000 g)